Clinical Study

Endothelial Dysfunction in Cystic Fibrosis: Role of Oxidative Stress

Table 2

Parameters of the FMD test in patients with CF completing the AOC treatment (CF-AOC; ), placebo condition (CF-PLC; ), or healthy controls ().

VariableCF-AOCCF-PLCControls
PrePostPrePost

Baseline diameter (cm)
Peak diameter (cm)
FMD absolute change (cm)
Shear rate (s-1, AUC)
FMD/shear (%/s-1, AUC)
Time to peak (s)†‡

Values are the . FMD = flow-mediated dilation. Significant pre- to posttreatment change versus CF-PLC (); significant difference versus Pre in CF-AOC (); significant difference versus Pre in CF-PLC ().